EKF Life Sciences manufactures diagnostic enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry.
EKF Life Sciences is based in Elkhart and South Bend, both in Indiana. Both facilities utilise bacterial fermentation and downstream processes to isolate and deliver the highest quality enzymes and biomolecules that are specially engineered to customers' specifications.
The fermentation facility is designed to produce micro-organisms including recombinant organisms for the manufacture of post-fermentation products such as enzymes, proteins and related biomaterials.
Our 21,000 sq.ft. manufacturing facility is ISO 13485:2016 certified with 12,000 square feet dedicated to fermentation production activities.
The plant routinely operates two segregated HEPA filtered fermentation suites with production vessels ranging from 40 liters to 1,600 liters. In 2022 a 14,500 liter stainless steel fermenter and 8,000 liter media preparation system were added to accommodate bulk orders.
Additional downstream processing equipment includes two AS-16 Super Sharples centrifuges located in a clean, HEPA filtered processing suite, a microfiltration unit for cell harvesting, two cell homogenizers, freeze drying unit for product processing and liquid nitrogen storage for cell banking.
EKF Life Sciences manufactures enzymes and related biomolecules from bacterial fermentation since 1983
Our team of experts work with early stage and mature processes to manufacture to ISO standards, and are committed to maintaining these standards as well as unparalleled customer service.
EKF Life Sciences' fermentation facilities are designed to produce microorganisms, including recombinant organisms, for clinically important enzymes and proteins used in many industrial applications. EKF Life Sciences enzymes are either sold in bulk or used in the production of in vitro diagnostic devices (IVDs).
Downstream processing applications are designed in order to address a multitude of client applications. EKF Life Sciences will work to customer specifications to produce a cell paste through various intermediary fractions to the final freeze drying of final product.
EKF Life Sciences manufacture enzymes used in clinical diagnostic reagents. These include:
These enzymes are used for the production Stanbio Chemistry branded reagents, OEM reagent production and are sold commercially for reagent production by third party clinical diagnostic companies.
Leverage our extensive manufacturing capabilities and many years of experience to produce your own quality products. Our ISO13485:2016 certified facility is conveniently located just 90 miles from Chicago in Elkhart, Indiana.
EKF Life Sciences is committed to the development, manufacture, and delivery of quality products that meet or exceed customer expectations that are in accordance with FDA regulations and ISO13485:2016 Standards (Medical Devices).
We are currently certified for ISO13485:2016 and have a successful inspection track record since our initial certification to ISO9001:1994 back in 1998.
EKF Life Sciences is also audited regularly by customers from various industries, and we work with them to meet their specific quality system requirements.
EKF Life Sciences has been manufacturing enzymes and related biomolecules from bacterial fermentation for use in IVD since 1983.
Since then it has developed core competencies in technology transfer to commercialization, and the scale up of fermentation processes from bench top vessels to manufacturing large scale stable and reliable enzymes. These enzymes can be consistently produced in bulk scale for mass production of test kits.
With the continued development of microbial expression platforms and the expanding interest in medical and industrial applications for biologically produced intermediates and products, EKF Life Sciences serves as a critical link in the evolution of improved and environmentally sensitive manufacturing processes.
Adding to this long history of service to the industry, in 2017 EKF Life Sciences announced a significant investment in its manufacturing capability, along with the appointment of Mike Salter, formerly of GE, as President, Americas.
Copyright © 2023 | Powered by Intergage